Almost 40% of shareholders vote down Novartis board package at AGM after first ever say-on-pay
AGM is first ever advisory vote on remuneration following investor campaign.
Almost 40% of shareholders at Novartis, the giant Swiss pharma company, today (February 22) voted against the company’s board pay after a vocal investor campaign against the CHF25m (€19.4m) market value of the package handed last year to board chairman, Daniel Vasella, and the CH…
You must have a SUBSCRIPTION or FREE TRIAL to view this PAID content.
Already got a Subscription or Free Trial?
Not got a Subscription or Free Trial?
One Free Trial per user; if your Free Trial has expired, please email email@example.com.